P.K. Suresh

880 total citations
39 papers, 656 citations indexed

About

P.K. Suresh is a scholar working on Molecular Biology, Oncology and Plant Science. According to data from OpenAlex, P.K. Suresh has authored 39 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Plant Science. Recurrent topics in P.K. Suresh's work include Natural product bioactivities and synthesis (6 papers), Nanoparticles: synthesis and applications (5 papers) and Bioactive Compounds and Antitumor Agents (3 papers). P.K. Suresh is often cited by papers focused on Natural product bioactivities and synthesis (6 papers), Nanoparticles: synthesis and applications (5 papers) and Bioactive Compounds and Antitumor Agents (3 papers). P.K. Suresh collaborates with scholars based in India, United States and Spain. P.K. Suresh's co-authors include Naveen Kumar Devanga Ragupathi, R. Ashok Kumar, Cijo George Vazhappilly, V. Rajkumar, M. R. Vijayababu, Arumugam Arunkumar, Suresh Kumar, J. Arunakaran, Natarajan Chandrasekaran and Amitava Mukherjee and has published in prestigious journals such as SHILAP Revista de lepidopterología, Chemosphere and International Journal of Pharmaceutics.

In The Last Decade

P.K. Suresh

34 papers receiving 632 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P.K. Suresh India 13 242 170 133 96 73 39 656
Anish Nag India 17 373 1.5× 245 1.4× 82 0.6× 205 2.1× 37 0.5× 59 1.0k
Elham Rouhollahi Malaysia 16 323 1.3× 211 1.2× 232 1.7× 42 0.4× 79 1.1× 30 892
Thiruventhan Karunakaran Malaysia 13 124 0.5× 176 1.0× 62 0.5× 172 1.8× 31 0.4× 41 591
Surya Kant Kalauni Nepal 18 508 2.1× 252 1.5× 82 0.6× 81 0.8× 55 0.8× 54 1.1k
Natthinee Anantachoke Thailand 14 259 1.1× 271 1.6× 37 0.3× 26 0.3× 52 0.7× 32 646
Wen‐Yun Gao China 19 563 2.3× 262 1.5× 48 0.4× 36 0.4× 150 2.1× 51 983
Arti Gupta India 14 169 0.7× 103 0.6× 37 0.3× 36 0.4× 21 0.3× 37 685
Mehreen Lateef Pakistan 14 231 1.0× 195 1.1× 41 0.3× 26 0.3× 84 1.2× 101 705
Fazli Nasir Pakistan 15 126 0.5× 84 0.5× 41 0.3× 88 0.9× 20 0.3× 49 753
Farkaad A. Kadir Malaysia 13 203 0.8× 142 0.8× 23 0.2× 97 1.0× 86 1.2× 22 847

Countries citing papers authored by P.K. Suresh

Since Specialization
Citations

This map shows the geographic impact of P.K. Suresh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.K. Suresh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.K. Suresh more than expected).

Fields of papers citing papers by P.K. Suresh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.K. Suresh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.K. Suresh. The network helps show where P.K. Suresh may publish in the future.

Co-authorship network of co-authors of P.K. Suresh

This figure shows the co-authorship network connecting the top 25 collaborators of P.K. Suresh. A scholar is included among the top collaborators of P.K. Suresh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.K. Suresh. P.K. Suresh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Das, Rajdeep, Sumitra Deb, & P.K. Suresh. (2025). TMB as a predictive biomarker for ICI response in TNBC: current evidence and future directions for augmented anti-tumor responses. Clinical and Experimental Medicine. 26(1). 25–25.
3.
Suresh, P.K., et al.. (2024). Capparis zeylanica-mediated Ag/ZnO nanoparticles and their antiproliferative efficacy via nuclear apoptosis. Advances in Traditional Medicine. 24(3). 935–946. 2 indexed citations
4.
Suresh, P.K., et al.. (2024). Targeting mitochondrial dynamics: an in-silico approach for repurposing antifungal drugs in OSCC treatment. Journal of Biomolecular Structure and Dynamics. 44(1). 220–233. 1 indexed citations
5.
Suresh, P.K., et al.. (2023). Antibiofilm, antibacterial and antioxidant activity of biofabricated bimetallic (Ag-ZnO) nanoparticles from Elephantopus scaber L. Biomass Conversion and Biorefinery. 14(17). 20911–20921. 5 indexed citations
6.
Suresh, P.K., et al.. (2023). Chemoresistance Mechanisms in Non-Small Cell Lung Cancer—Opportunities for Drug Repurposing. Applied Biochemistry and Biotechnology. 196(7). 4382–4438. 5 indexed citations
8.
Suresh, P.K., et al.. (2020). UVB pre-irradiation of titanium dioxide nanoparticles is more detrimental to freshwater algae than UVA pre-irradiation. Journal of environmental chemical engineering. 8(5). 104076–104076. 22 indexed citations
10.
Suresh, P.K., et al.. (2018). Enhanced Induction of Apoptosis in HaCaT Cells by Luteolin Encapsulated in PEGylated Liposomes—Role of Caspase-3/Caspase-14. Applied Biochemistry and Biotechnology. 188(1). 147–164. 27 indexed citations
11.
Suresh, P.K., et al.. (2017). Phenytoin-Bovine Serum Albumin interactions - modeling plasma protein – drug binding: A multi-spectroscopy and in silico-based correlation. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 193. 523–527. 27 indexed citations
12.
Suresh, P.K., et al.. (2015). ABC transporters in anticancer drug transport ? Lessons for Therapy,Drug Development and Delivery Systems. International Journal of Drug Development and Research. 7(1). 4 indexed citations
13.
Vazhappilly, Cijo George, Naveen Kumar Devanga Ragupathi, P.K. Suresh, & R. Ashok Kumar. (2015). Luteolin induces caspase-14-mediated terminal differentiation in human epidermal keratinocytes. In Vitro Cellular & Developmental Biology - Animal. 51(10). 1072–1076. 4 indexed citations
14.
Vazhappilly, Cijo George, Naveen Kumar Devanga Ragupathi, P.K. Suresh, & R. Ashok Kumar. (2014). Antioxidant, DNA protective efficacy and HPLC analysis of Annona muricata (soursop) extracts. Journal of Food Science and Technology. 52(4). 2328–2335. 118 indexed citations
15.
Suresh, P.K., et al.. (2013). COMPUTATIONAL TOXICITY ANALYSIS OF PERSISTENT ORGANIC POLLUTANTS IMPLICATED IN ENDOMETRIOSIS USING THE MODELED HUMAN ARYL HYDROCARBON RECEPTOR. International Journal of Pharma and Bio Sciences. 1 indexed citations
16.
Suresh, P.K., et al.. (2013). Comparative anti-inflammatory activity of poly(amidoamine) (PAMAM) dendrimer–dexamethasone conjugates with dexamethasone-liposomes. International Journal of Pharmaceutics. 449(1-2). 28–36. 28 indexed citations
18.
Vazhappilly, Cijo George, Naveen Kumar Devanga Ragupathi, V. Rajkumar, P.K. Suresh, & R. Ashok Kumar. (2012). Quantitative Assessment of the Relative Antineoplastic Potential of the n-butanolic Leaf Extract of Annona Muricata Linn. in Normal and immortalized Human Cell Lines. Asian Pacific Journal of Cancer Prevention. 13(2). 699–704. 103 indexed citations
19.
Ragupathi, Naveen Kumar Devanga, Cijo George Vazhappilly, P.K. Suresh, & R. Ashok Kumar. (2012). Cytotoxicity, Apoptosis Induction and Anti-Metastatic Potential of Oroxylum indicum in Human Breast Cancer Cells. Asian Pacific Journal of Cancer Prevention. 13(6). 2729–2734. 47 indexed citations
20.
Vazhappilly, Cijo George, Naveen Kumar Devanga Ragupathi, P.K. Suresh, & R. Ashok Kumar. (2012). Apoptosis-Induced Cell Death due to Oleanolic Acid in HaCaT Keratinocyte Cells -a Proof-of-Principle Approach for Chemopreventive Drug Development. Asian Pacific Journal of Cancer Prevention. 13(5). 2015–2020. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026